In adhesion between MB435 and HBMEC-60 (A), from 0.5 to 30 to 60 sec contact times, total adhesion forces were significantly reduced by antibodies to TF-Ag and β1 showing descending inhibition dynamics with the highest inhibition at 0.5 sec, compared to the baseline; while anti-α3 and anti-Gal-3 showed ascending inhibition dynamics with the highest inhibition at 60 sec. As positive control, activating β1 antibody (Activ β1) induced the greatest adhesion (64.55%) at 0.5 sec, which is in agreement with what was observed with inhibiting anti-β1 antibody. In adhesion between MB231 and HBMEC-60 (B), significant inhibition was observed at the 60 sec contact time with antibodies against TF-Ag (-23.26%), β1 (-23.81%) and Gal-3 (-41.71%), but not st...
<p>HUVECs were treated at 37°C and 5% CO<sub>2</sub> with a mixture of 10 ng/ml IL-1ß and 10 µg/ml a...
<p>MDDCs (<b>A</b>), MDMs (<b>B</b>) and monocytes (<b>C</b>) were treated with monoclonal anti-CD11...
Multicellular resistance, a subtype of therapeutic resistance manifested in cancer cells grown as th...
There were no changes seen in rupture distribution in CO2IM treated control (A, B and C). Function-i...
No obvious changes were detected in rupture distribution in CO2IM treated controls (A-C) compared to...
grantor: University of TorontoSeveral studies have documented a correlation between cell-c...
<p>(<b>a</b>) Effect of 10 new anti-MFGE8 antibodies (10 or 50 µg/mL) on adhesion to MFGE8 (adhesion...
Note 3.89-fold increase (from 903 to 3516 counts) in the frequency counts of the detectable rupture ...
<p>(<i>A</i>) Adhesion probability was measured for cells treated with histamine, Aβ, lovastatin and...
<p>Panel A, Blocking with anti-β7. HMCLs were stimulated with Pam3CSK4 for 24 hours and then treated...
Representative curves for AFM cantilever retraction that were recorded in the experiments were plott...
<p><i>A.</i> shRNA-scramble HBMECs or shRNA-CXCR7 HBMECs were seeded on matrigel or GBM cells (U251 ...
<p>(<b>a</b>–<b>b</b>) Adhesion of IGROV-1 (a) and SHIN-3 (b) to 5 µg/mL MFGE8, as compared to PBS, ...
<p>The inhibition of αvβ3 can lower the adhesion ability of EPCs. A, Representative macroscopic phot...
Multicellular resistance, a subtype of therapeutic resistance manifested in cancer cells grown as th...
<p>HUVECs were treated at 37°C and 5% CO<sub>2</sub> with a mixture of 10 ng/ml IL-1ß and 10 µg/ml a...
<p>MDDCs (<b>A</b>), MDMs (<b>B</b>) and monocytes (<b>C</b>) were treated with monoclonal anti-CD11...
Multicellular resistance, a subtype of therapeutic resistance manifested in cancer cells grown as th...
There were no changes seen in rupture distribution in CO2IM treated control (A, B and C). Function-i...
No obvious changes were detected in rupture distribution in CO2IM treated controls (A-C) compared to...
grantor: University of TorontoSeveral studies have documented a correlation between cell-c...
<p>(<b>a</b>) Effect of 10 new anti-MFGE8 antibodies (10 or 50 µg/mL) on adhesion to MFGE8 (adhesion...
Note 3.89-fold increase (from 903 to 3516 counts) in the frequency counts of the detectable rupture ...
<p>(<i>A</i>) Adhesion probability was measured for cells treated with histamine, Aβ, lovastatin and...
<p>Panel A, Blocking with anti-β7. HMCLs were stimulated with Pam3CSK4 for 24 hours and then treated...
Representative curves for AFM cantilever retraction that were recorded in the experiments were plott...
<p><i>A.</i> shRNA-scramble HBMECs or shRNA-CXCR7 HBMECs were seeded on matrigel or GBM cells (U251 ...
<p>(<b>a</b>–<b>b</b>) Adhesion of IGROV-1 (a) and SHIN-3 (b) to 5 µg/mL MFGE8, as compared to PBS, ...
<p>The inhibition of αvβ3 can lower the adhesion ability of EPCs. A, Representative macroscopic phot...
Multicellular resistance, a subtype of therapeutic resistance manifested in cancer cells grown as th...
<p>HUVECs were treated at 37°C and 5% CO<sub>2</sub> with a mixture of 10 ng/ml IL-1ß and 10 µg/ml a...
<p>MDDCs (<b>A</b>), MDMs (<b>B</b>) and monocytes (<b>C</b>) were treated with monoclonal anti-CD11...
Multicellular resistance, a subtype of therapeutic resistance manifested in cancer cells grown as th...